Vivacelle Bio
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02) (NCT06072430) | Vivacelle Bio | 2024-08-06 |
| VBI-S for the Treatment of Hypotension in Hypovolemic Septic Shock Patients (NCT04257136) | Vivacelle Bio | 2020-02-17 |
Track Vivacelle Bio automatically
Every clearance here is in the API, with alerts when new ones post.